David Nadel (Trades, Portfolio), portfolio manager for Royce International Premier Fund, bought and sold stakes in his most noteworthy fourth-quarter transactions, focusing largely on pharmaceutical and health care-oriented companies.
Nadel sold his 22,500-share stake in Abcam PLC (LSE:ABC, Financial), a British biotechnology and life sciences company, for an average price of £9.06 ($13.04 in U.S. currency) per share. The divestiture had a -2.49% impact on his portfolio.
Abcam’s leading shareholder among the gurus is Wasatch International Growth (Trades, Portfolio) with a stake of 3,263,052 shares. The stake is 1.61% of Abcam’s outstanding shares and 2.35% of Wasatch’s total assets.
Abcam has a P/E of 32.7, a forward P/E of 27.3, a P/B of 5.2 and a P/S of 7.6. GuruFocus gives Abcam a Financial Strength rating of 9/10 with no debt and a Profitability and Growth rating of 8/10.
Abcam sold for £5.9 ($8.49 in American money) per share Thursday.
Nadel sold his 170-share stake in Forbo Holding AG (XSWX:FORN, Financial), a Swiss maker of floor coverings, building and construction adhesives and power transmission and light conveyor belts, for an average price of CHF1,040.22 ($1,077.90 in U.S. dollars) per share. The divestiture had a -2.4% impact on Nadel’s portfolio.
Forbo has a P/E of 18.8, a P/B of 3.6 and a P/S of 1.9. GuruFocus gives Forbo a Financial Strength rating of 7/10 and a Profitability and Growth rating of 6/10.
Forbo sold for CHF1,165 ($1,207.20 in American currency) per share Wednesday.
Nadel sold his 7,700-share stake in Recordati (MIL:REC, Financial), a Milan-based pharmaceutical group, for an average price of €25.7 ($29.07 in U.S. dollars) per share. The divestiture had a -2.23% impact on Nadel’s portfolio.
Recordati has a P/E of 22.9, a P/B of 5.2 and a P/S of 4.3. GuruFocus gives Recordati a Financial Strength rating of 9/10 and a Profitability and Growth rating of 9/10.
Recordati sold for €22 ($24.89 in American money) per share Wednesday.
Nadel sold his 9,000-share stake in TGS-NOPEC Geophysical Co. ASA (OSL:TGS, Financial), a Norwegian geosciences company, for an average price of Kr19.29 ($2.31 in U.S. currency) per share. The divestiture had a -2.09% impact on Nadel’s portfolio.
Bestinfond (Trades, Portfolio) is TGS-NOPEC Geophysical’s leading shareholder among the gurus with a stake of 620,637 shares. The stake is 0.61% of the company’s outstanding shares and 0.81% of the guru’s total assets.
TGS-NOPEC Geophysical has a P/E of 13.5, a forward P/E of 26.5, a P/B of 1.2 and a P/S of 2. GuruFocus gives the company a Financial Strength rating of 8/10 with no debt and a Profitability and Growth rating of 9/10.
TGS-NOPEC Geophysical sold for Kr129.3 ($15.48 in American dollars) per share Wednesday, a 570% increase over the fourth-quarter average.
Nadel sold the 5,000-share stake in Nokian Tyres PLC (OHEL:NRE1V, Financial), a Finnish producer of tires for cars, trucks, buses and heavy-duty equipment, that the guru acquired in the second quarter, receiving an average price of €31.33 ($35.44 in U.S. money) per share. The divestiture had a -2.03% impact on Nadel’s portfolio.
Nokian Tyres has a P/E of 17.3, a forward P/E of 14.1, a P/B of 3.4 and a P/S of 3.1. GuruFocus gives Nokian Tyres a Financial Strength rating of 7/10 and a Profitability and Growth rating of 8/10.
Nokian Tyres sold for €31.28 ($35.38 in American currency) per share Wednesday.
Nadel acquired a 4,700-share stake in Gaztransport et technigaz SA (XPAR:GTT), a French company involved in cryogenics and storage of liquefied gases, for an average price of €44.38 ($50.20 in U.S. dollars) per share. The transaction had a 1.66% impact on Nedal’s portfolio.
The stake is 0.01% of the company’s outstanding shares and 1.66% of Nadel’s total assets.
Gaztransport has a P/E of 9.8, a forward P/E of 8, a P/B of 12.1 and a P/S of 5. GuruFocus gives the company a Financial Strength rating of 3/10 and a Profitability and Growth rating of 4/10.
Gaztransport sold for €28.92 ($32.72 in American money) per share Wednesday.
Nadel purchased a 32,500-share stake in Fisher & Paykel Healthcare Corp Ltd. (NZSE:FPH), a health care devices company based in New Zealand, for an average price of NZD 7.99 ($5.51 in U.S. currency) per share. The deal had a 1.64% impact on Nadel’s portfolio.
The stake is 0.01% of Fisher & Paykel’s outstanding shares and 1.64% of Nadel’s total assets.
Fisher & Paykel has a P/E of 42.3, a forward P/E of 34.5, a P/B of 12 and a P/S of 6.9. GuruFocus gives the company a Financial Strength rating of 8/10 and a Profitability and Growth rating of 8/10.
Fisher & Paykel sold for NZD 9.8 ($6.76 in American dollars) per share Thursday.
Nadel bought an 11,500-share stake in Addtech AB (OSTO:ADDT B), a Swedish technology trading group, for an average price of Kr119.83 ($14.35 in U.S. money) per share. The transaction had a 1.63% impact on Nadel’s portfolio.
The stake is 0.02% of Addtech’s outstanding shares and 1.63% of Nadel’s total assets.
Addtech has a P/E of 19, a P/B of 4.2 and a P/S of 1. GuruFocus gives Addtech a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10.
Addtech sold for Kr112.5 ($13.47 in American currency) per share Wednesday.
Nadel purchased a 90,000-share stake in Exova Group PLC (LSE:EXO), a British-based materials testing company, for an average price of £1.56 ($2.25 in U.S. dollars) per share. The deal had a 1.6% impact on Nadel’s portfolio.
The stake is 0.04% of Exova’s outstanding shares and 1.6% of Nadel’s total assets.
Exova has a P/E of 22.9, a forward P/E of 13.7, a P/B of 1.4 and a P/S of 1.4. GuruFocus gives Exova a Financial Strength rating of 5/10 and a Profitability and Growth rating of 5/10.
Exova sold for £1.6 ($2.30 in American money) per share Thursday.
Nadel bought an 11,500-share stake in Santen Pharmaceutical Co. Ltd. (TSE:4536), a Japanese pharmaceutical company, for an average price of ¥1,813.8 ($16.13 in U.S. currency) per share. The transaction had a 1.58% impact on Nadel’s portfolio.
The stake is 1.58% of Nadel’s total assets.
Santen Pharmaceutical has a P/E of 12.7, a P/B of 2.8 and a P/S of 3.7. GuruFocus gives Santen a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10.
Santen sold for ¥1,693 ($15.05 in American dollars) per share Thursday.
Nadel invested in an 8,600-share stake in XP Power Ltd. (LSE:XPP), a provider of power solutions, for an average price of £14.77 ($21.26 in U.S. money) per share. The deal had a 1.54% impact on Nadel’s portfolio.
The stake is 0.04% of XP Power’s outstanding shares and 1.54% of Nadel’s total assets.
XP Power has a P/E of 15.4, a P/B of 3.5 and a P/S of 2.8. GuruFocus gives XP Power a Financial Strength rating of 7/10 and a Profitability and Growth rating of 8/10.
XP Power sold for £16 ($23.03 in American currency) per share Thursday.
Nadel acquired a 7,500-share stake in Nihon Kohden Corp. (TSE:6849), a Tokyo-based medical electronic equipment company, for an average price of ¥2,478.11 ($22.03 in U.S. dollars) per share. The transaction had a 1.51% impact on Nadel’s portfolio.
The stake is 0.01% of Nihon Kohden’s outstanding shares and 1.51% of Nadel’s total assets.
Nihon Kohden has a P/E of 27.5, a P/B of 2.5 and a P/S of 1.5. GuruFocus gives Nihon Kohden a Financial Strength rating of 9/10 and a Profitability and Growth rating of 7/10.
Nihon Kohden sold for ¥2,798 ($24.87 in American money) per share Thursday.
Nadel purchased a 76,000-share stake in ITE Group PLC (LSE:ITE), a London-based organizer of exhibitions and conferences, for an average price of £1.49 ($2.14 in U.S. currency) per share. The deal had a 1.47% impact on Nadel’s portfolio.
The stake is 0.03% of ITE Group’s outstanding shares and 1.47% of Nadel’s total assets.
ITE Group has a P/E of 14.5, a forward P/E of 11.7, a P/B of 4.5 and a P/S of 2.7. GuruFocus gives ITE Group a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10.
ITE Group sold for £1.47 ($2.12 in American dollars) per share Thursday.
To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for seven days.
